Literature DB >> 21309500

The frequency of HLA class I and II alleles in Turkish childhood acute leukaemia patients.

K Ozdilli1, F S Oguz, S Anak, C Kekik, M Carin, G Gedikoglu.   

Abstract

In this study, blood samples were taken from 200 patients with childhood acute leukaemias, including acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML), and from 100 healthy volunteers (controls). The frequency of the human leucocyte antigen (HLA)-DRB1*04 allele was significantly higher, and the frequencies of the HLA-A23 and HLA-B7 antigens were significantly lower, in patients with ALL compared with controls. Among patients with AML, the frequency of the HLA-B49 antigen and the HLA-DRB1*15 allele were significantly higher, whereas the frequencies of the HLA-A11 and HLA-B38 antigens were significantly lower compared with controls. The frequency of the HLA-DRB1*04 allele was also significantly higher in male patients with ALL and AML, whereas the HLA-DRB1*13 allele was found significantly less frequently in male AML and female ALL patients than in controls. To date, this is the only study to evaluate the associations between HLA molecules and leukaemia in a Turkish population with acute childhood leukaemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21309500     DOI: 10.1177/147323001003800531

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  6 in total

1.  Human leukocyte antigen-DRB1 polymorphism in childhood acute lymphoblastic leukemia.

Authors:  Mervat M El Ansary; Lamiaa A Mohammed; Tamer H Hassan; Ahmed Baraka; Alshymaa A Ahmed
Journal:  Mol Clin Oncol       Date:  2014-11-25

2.  The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms.

Authors:  Khanh Vinh Quốc Lu'o'ng; Lan Thi Hoàng Nguyễn
Journal:  Cancer Manag Res       Date:  2012-12-18       Impact factor: 3.989

3.  Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia.

Authors:  Kateřina Kuželová; Barbora Brodská; Ota Fuchs; Marie Dobrovolná; Petr Soukup; Petr Cetkovský
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

4.  A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.

Authors:  Ena Wang; Yingdong Zhao; Alessandro Monaco; Lorenzo Uccellini; John M Kirkwood; Maria Spyropoulou-Vlachou; Monica C Panelli; Francesco M Marincola; Helen Gogas
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

Review 5.  Genetic variation in the extended major histocompatibility complex and susceptibility to childhood acute lymphoblastic leukemia: a review of the evidence.

Authors:  Kevin Y Urayama; Pamela D Thompson; Malcolm Taylor; Elizabeth A Trachtenberg; Anand P Chokkalingam
Journal:  Front Oncol       Date:  2013-12-12       Impact factor: 6.244

6.  The Frequency of HLA-A, HLA-B, and HLA-DRB1 Alleles in Patients with Acute Lymphoblastic Leukemia in the Turkish Population: A Case-Control Study.

Authors:  Türkan Patıroğlu; H Haluk Akar
Journal:  Turk J Haematol       Date:  2016-04-18       Impact factor: 1.831

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.